iiinova — where your digital self keeps evolving

Sanjay Popat @drsanjaypopat.bsky.social · 05/03/2025

With the successful role out of the TLHC programme, we now have a growing cohort of stage 1 SCLC patients. Hopefully this will become even more common, and work needed to understand optimal patient management @drjnaidoo.bsky.social #BTOG25

0134

Agree. A packed room for SCLC on the last day of a conference? Unheard of previously! Obviously all attending to listen to @annaminchom.bsky.social , @drjnaidoo.bsky.social ,& @stephenvliu.bsky.social! @btog.bsky.social #BTOG25

0135

Reposted by Sanjay Popat

Yvonne Diaz @yvonnediaz.bsky.social · 05/03/2025

@annaminchom.bsky.social on newer small cell therapeutic strategies and management of CRS and ICANS as specific TRAEs With thought around timings of dose delivery and education of AOS teams and patients, safely deliverable within the NHS #BTOG25

187

Reposted by Sanjay Popat

Professor @drjnaidoo.bsky.social welcomed to the #BTOG25 stage as a Lung Cancer Legend & doesn’t disappoint. Lots of discussion on how we turn discussions on Small Cell Lung Cancer on its head. Lots of optimism in #SCLC coming from new standards & future treatments. #LCSM

0187

Reposted by Sanjay Popat

DrLJ @drlaurajane.bsky.social · 05/03/2025

At #BTOG25 & I tringied by Matt’s comment on the fact that GP practices who request more chest X-rays have less stage III/IV #lungcaner disease? Read more here! www.respiratoryfutures.org.uk/features/dia...

respiratoryfutures.org.uk

Diagnosing Lung Cancer: X-rays & CT Scans | Respiratory Futures

Learn how chest x-rays and CT scans aid in diagnosing lung cancer and the role of primary care in early detection.

031

Reposted by Sanjay Popat

DrLJ @drlaurajane.bsky.social · 05/03/2025

We really need to make sure people know this!! It’s never too late to quit smoking. Treating tobacco dependence is cancer treatment! We would not let this survival benefit pass us by of this was a new oncology drug. #BTOG25

072

Reposted by Sanjay Popat

Chloe Waterson @chloewaterson.bsky.social · 05/03/2025

So what's the point in quitting smoking once you've already been diagnosed with cancer? Quitting in the first 6 months could add extra years to survival! #BTOG25

073

Reposted by Sanjay Popat

@stephenvliu.bsky.social on excitement in the Small Cell arena. PDL1/PD1 inhibition a practice changer, but so many potential game changers on the horizon from BITES To ADC, it’s exciting to see new drugs for an area of unmet need #BTOG25

0145

Reposted by Sanjay Popat

@drjnaidoo.bsky.social on the limited stage small cell space and the excitement around CCRT-Durvalumab. EAMS currently open in England… #BTOG25

0105

Reposted by Sanjay Popat

BTOG @btog.bsky.social · 05/03/2025

Small cell in never smokers. On the rise for unknow reasons and a different biology. Having recently encountered my first patient who’s a never smoker(and no alcohol or recreational drugs), with extensive stage disease this insight is fascinating @stephenvliu.bsky.social #BTOG25

2276

Reposted by Sanjay Popat

We are delighted to announce that the 2025 BTOG Lifetime Achievement Award has been presented to Professor Cindy Billingham. The announcement was made by Professor Gary MIddleton and hosted at the 23nd BTOG Annual Conference in Belfast by Professor @drsanjaypopat.bsky.social #BTOG25 #LCSM

092

Reposted by Sanjay Popat

Oncogene Cancer Research @oncogenecancer.bsky.social · 05/03/2025

Historic moment at #BTOG25 at last evening’s dinner where Professor @drsanjaypopat.bsky.social finished his 13 year tenure as BTOG Chair & heralded the great progress. The reigns (& clapper) hv now been handed to Dr @tnewsomdavis.bsky.social. Patient advocates grateful for progress & keen for more

092

Reposted by Sanjay Popat

Tom Newsom-Davis @tnewsomdavis.bsky.social · 04/03/2025

Fun #BTOG25 fun-run fun Excellent turnout by the hardier / insane delegates

051

Reposted by Sanjay Popat

Sandi Deans in delivering a 14 day genomics service, and the impact of the ctDNA pilots and roll out in potential time saving. CtDNA now pending addition to the Directory @BTOG25

0103

Reposted by Sanjay Popat

Caught the most amazing sunrise en route to the #BTOG25 5km… there are some benefits to wandering the streets at 6:30am 🤣

2151

Reposted by Sanjay Popat

Yvonne Diaz @yvonnediaz.bsky.social · 04/03/2025

Matthew Krebs on ctDNA and moving away from confirmatory tissue testing where an informative result is present. Key number 1% VAF for determining of non-actionable mutations are informative #BTOG25

031

Reposted by Sanjay Popat

Speed to diagnosis is key for ppl w #lungcancer- many of us are diagnosed at stage 4 when unwell. Great talk from Sandi Deans @nhsenglandldn.bsky.social Genomics at #BTOG25, illustrating the ideal pathway to reach the 14-day turnaround target in UK. Good to see ctDNA here #LCSM @btog.bsky.social

095

Sanjay Popat @drsanjaypopat.bsky.social · 04/03/2025

One of the most powerful phrases heard at this conference. Bravo @alkpositiveuk.bsky.social #BTOG25 @btog.bsky.social

182

Reposted by Sanjay Popat

ALK Positive Lung Cancer UK @alkpositiveuk.bsky.social · 04/03/2025

Out now! Faster Testing, Better Outcomes: genomic testing in #lungcancer from @uklungcancer.bsky.social Important recommendations #BTOG25

021

Reposted by Sanjay Popat

At #BTOG25, our Chair, Debra Montague, addressed: Have we lost the patient voice in genomics? #lungcancer patients must be at the heart of genomic advances. With the focus often on technology & turnaround times, this was a chance to put patient experiences at the centre of the conversation. #LCSM

082

Sanjay Popat @drsanjaypopat.bsky.social · 04/03/2025

Ama amazing and packed session. Bravo to speakers and chairs! @btog.bsky.social #BTOG25

021

Reposted by Sanjay Popat

Gerry Hanna @gerryhanna.bsky.social · 04/03/2025

My takeaways 👇 ➡️ uncertainty regarding benefit of peri-operative vs pre-op ChemoIO ➡️ EORTC guidelines give us a steer on surgical resectability ➡️ Radiotherapy and CRT being using post pre-op ChemoIO if patient no longer operable ➡️ Role of PORT needs re-examined in higher risk disease #BTOG25

022

Reposted by Sanjay Popat

There are any trials of IO at multiple parts of pathway. Neoadj, adj, period. Growing area. Complex & sometimes burdensome for patients but potential benefits. #BTOG25

011

Reposted by Sanjay Popat

Great summary of debates over what operable means, incl consensus statement & its limitations. Difficult to ascertain place of chemo-RTX in N2 disease when surgical approaches differ across centres… #BTOG25

011

Reposted by Sanjay Popat

Great presentation on risk of major CV events in patients with coronary calcification on #lungcancer screening. It matters. Next step: find out what interventions work & how to deliver equitably at scale! #BTOG25

032

Reposted by Sanjay Popat